UA107447C2 - Method for assessment of the anti-anginal effect of propranolol in patients with coronary heart disease with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle
- Google Patents
Method for assessment of the anti-anginal effect of propranolol in patients with coronary heart disease with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uzhgorod Nat Univ State Higher Educational EstabfiledCriticalUzhgorod Nat Univ State Higher Educational Estab
Priority to UAA201104947ApriorityCriticalpatent/UA107447C2/en
Publication of UA107447C2publicationCriticalpatent/UA107447C2/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The invention relates to medicine, and more particularly, to cardiology, and may be used to objectively assess the anti-anginal effect of propranolol in patients with coronary heart disease (CHD) with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle.
UAA201104947A2011-04-202011-04-20Method for assessment of the anti-anginal effect of propranolol in patients with coronary heart disease with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle
UA107447C2
(en)
Method for assessment of the anti-anginal effect of propranolol in patients with coronary heart disease with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle
Method for assessment of the anti-anginal effect of propranolol in patients with coronary heart disease with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle
Method for assessment of the anti-anginal effect of propranolol in patients with coronary heart disease with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle
composition, dosage form, and methods for reducing the risk for mortality in an individual, the risk for a disease or condition in an individual, triglycerides in an individual's blood, an individual's resting heart rate, lipoprotein cholesterol non-high density in an individual, total cholesterol in an individual, apolipoprotein b in an individual blood, systolic blood pressure in an individual, and diastolic blood pressure in an individual, to prolong an individual's life, to treat hypertriglyceridemia in an individual and to increase an omega-3 index in an individual's red blood cells.
Method for assessment of the anti-anginal effect of propranolol in patients with coronary heart disease with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle
Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction
Method of assessment of the effectiveness of treatment s-metoprolol patients with coronary heart disease with angina and hypertension in violation of left ventricular diastolic function in "hypertrophic" type
Method for assessing efficacy of s-atenolol in treatment of ischemic heart disease with angina and arterial hypertension with hypertrophic type of impaired diastolic function of left ventricle
Method for assessing treatment efficacy of isosorbid dinitrate in patients with ischemic heart disease suffering from angina pectoris and arterial hypertension
Method for assessment of fenofibrate efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
Method for assessment of azilsartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of the ventricle according to "hypertrophic" type
Method for assessment of irbesartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
Method for assessing efficacy of cilasapril treatment in patients with ischemic heart disease, angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
Method for assessing efficacy of oxprenolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
method for evaluating the effectiveness of treatment with candesartan of patients with coronary heart disease with angina pectoris and hypertension at disorder of the left ventricular diastolic function by "hypertrophic" type
Method for assessment of olmesartan efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type
Method for assessment of pitavastatin efficacy in treatment of patients with ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to "hypertrophic" type
Method for assessing efficacy of celiprolol treatment in patients with ischemic heart disease, cardiac angina and arterial hypertension with impaired diastolic function of left ventricle of 'hypertrophic' type
Method for assessing efficacy of pravastatin in treating ischemic heart disease with angina pectoris and arterial hypertension with impairment of diastolic function of left ventricle according to hypertrophic type